Key Highlights
- Hone Health surpasses 300,000 patients tested and 55,000 treated.
- Raises $33M in Series A funding, bringing total funding to $39M.
- Investors include Tribe Capital, Republic Capital, and PIF.
- Acquires ivee to expand in-home healthcare services.
- Advancing longevity care for both men and women.
Source: Business Wire
Notable Quotes
- “Securing this investment is a pivotal moment for Hone Health. It allows us to capitalize on the shift from the broken primary care model to one that helps people live longer while staying healthy as they age.” — Saad Alam, Co-founder and CEO at Hone Health
- “Hone Health has quickly emerged as a leader in men’s health, prioritizing patient safety and delivering a unique, comprehensive solution that addresses critical market needs. We are excited to support their next phase of growth as they continue to expand their footprint into longevity and holistic healthcare.” — Ted Maidenberg, Partner at Tribe Ventures
Why This Matters
Hone Health’s $33M Series A funding signals a major step forward in transforming preventative healthcare. By integrating cutting-edge telemedicine, at-home biomarker testing, and personalized treatment plans, the company is redefining longevity care. The acquisition of ivee further strengthens its mission by expanding in-home healthcare services, ensuring more patients have access to high-quality, personalized medical care. With an emphasis on safety, innovation, and holistic wellness, Hone Health is poised to reshape the future of aging and longevity care for both men and women.
